论文部分内容阅读
心房颤动是临床上最常见的心律失常之一,是其他心律失常总和的2倍,其发生率及流行范围逐年增加。心房颤动是老年人发生卒中的危险因素之一,还可以增加致残率。近年来有大量报导证明,非抗心律失常药物在心房颤动的治疗方面具有一定的作用。现将近年来有关非抗心律失常药物治疗心房颤动作用机制及临床试验结果作一综述。
Atrial fibrillation is one of the most common clinical arrhythmias, which is 2 times the sum of other arrhythmias. The incidence and prevalence of atrial fibrillation are increasing year by year. Atrial fibrillation is one of the risk factors for stroke in the elderly and can also increase the morbidity. In recent years, a large number of reports have proved that non-antiarrhythmic drugs play a role in the treatment of atrial fibrillation. Now in recent years, non-antiarrhythmic drugs for the treatment of atrial fibrillation mechanism and clinical trial results are reviewed.